Apotex Inc - Company Profile
Powered by 
All the sales intelligence you need on Apotex Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Apotex Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Apotex Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Apotex Catalyst Calendar
Proactively evaluate Apotex Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Apotex Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 09 Oct 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 21 Sep 2021 | Phase III Trial Completion | Apotex Inc; Canadian Breast Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Cancer Trials Group; Cancer Research UK; Experimental Cancer Medicine Centre Network; Institute of Cancer Research; International Breast Cancer Study Group; Montefiore Medical Center; National Cancer Institute US; National Cancer Research Network; National Institute for Health and Care Research; The Breast Cancer Research Foundation Inc; U.S. National Institutes of Health | - | Apozemia | Oncology | Breast Cancer | Clinical Trial Registry |
| 20 Sep 2020 | Phase II Trial Completion | ApoPharma Inc; European Clinical Research Infrastructures Network; European Commission; European Commission H2020 Program; French Clinical Research Infrastructure Network; Lille Regional University Hospital Centre; University Hospital of Lille | - | deferiprone | Central Nervous System; Toxicology | Iron Poisoning; Parkinson's Disease | Clinical Trial Registry |
| 06 Dec 2019 | Phase II Trial Completion | ApoPharma Inc | - | deferiprone DR | Hematological Disorders | Sickle Cell Disease; Thalassemia | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer